Skip to main content

Table 2 EMBASE search strategy

From: Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol

Search steps
1. Imatinib Mesylate/
2. bexarotene.mp.
3. Busulfan/
4. Capecitabine/
5. Chlorambucil/
6. Cyclophosphamide/
7. Estramustine/
8. Etoposide/
9. Hydroxyurea/ or hydroxycarbamide.mp.
10. Melphalan/
11. mercaptopurine.mp. or 6-Mercaptopurine/
12. Lomustine/
13. Mitotane/
14. Procarbazine/
15. Tegafur/
16. temozolomide.mp.
17. Thioguanine/
18. Topotecan/
19. treosulfan.mp.
20. Tretinoin/
21. Trifluridine/
22. vinorelbine.mp.
23. afatinib.mp.
24. axitinib.mp.
25. bosutinib.mp.
26. cabozantinib.mp.
27. cobimetinib.mp.
28. crizotinib.mp.
29. ceritinib.mp.
30. dabrafenib.mp.
31. Dasatinib/
32. Erlotinib Hydrochloride/
33. Everolimus/
34. gefitinib.mp.
35. ibrutinib.mp.
36. idelalisib.mp.
37. lapatinib.mp.
38. nilotinib.mp.
39. nintedanib.mp.
40. olaparib.mp.
41. osimertinib.mp.
42. panobinostat.mp.
43. pazopanib.mp.
44. ponatinib.mp.
45. regorafenib.mp.
46. ruxolitinib.mp.
47. sorafenib.mp.
48. sunitinib.mp.
49. temsirolimus.mp.
50. trametinib.mp.
51. vandetanib.mp.
52. vemurafenib.mp.
53. vismodegib.mp.
54. Thalidomide/
55. lenalidomide.mp.
56. pomalidomide.mp.
57. anastrozole.mp.
58. exemestane.mp.
59. letrozole.mp.
60. Tamoxifen/
61. Toremifene/
62. Abiraterone Acetate/
63. bicalutamide.mp.
64. Cyproterone/ or Cyproterone Acetate/
65. enzalutamide.mp.
66. Flutamide/
67. Medroxyprogesterone/or Medroxyprogesterone Acetate/
68. Megestrol/or Megestrol Acetate/
69. norethisterone.mp. or Norethindrone/
70. Diethylstilbestrol/
71. Ethinyl Estradiol/or ethinylestradiol.mp.
72. Idarubicin/
73. Methotrexate/
74. Trifluridine/
75. lenvatinib.mp.
76. venetoclax.mp.
77. ixazomib.mp.
78. Palbociclib.mp.
79. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78
80. antineoplastic agent/ad [Drug Administration]
81. antineoplastic agent/dt [Drug Therapy]
82. antineoplastic agent/po [Oral Drug Administration]
83. antineoplastic agent/do [Drug Dose]
84. 80 or 81 or 82 or 83
85. (reduc* or attenuat* or discontinu* or modif* or dosing or schedul* or strateg* or dosage* or intercalat* or alternat* or personali* or break or holiday* or cessation or interrup* or intermit* or escala* or prescrib* or optimis* or optimiz* or tailor* or individuali* or "non conventional*" or nonconventional* or "non standard*" or nonstandard* or "treatment free").ab,ti.
86. (reduc* or attenuat* or discontinu* or modif* or dosing or schedul* or strateg* or dosage* or intercalat* or alternat* or personali* or break or holiday* or cessation or interrup* or intermit* or escala* or prescrib* or optimis* or optimiz* or tailor* or individuali* or "non conventional*" or nonconventional* or "non standard*" or nonstandard* or "treatment free").ti.
87. 79 and 84 and 85
88. 79 and 84 and 86